Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Goodwill & Intangibles (2019 - 2026)

Viatris (VTRS) posted Goodwill & Intangibles of $20.3 billion for Q2 2026, down 3.98% on a QoQ basis from $21.2 billion in Q1 2026, and down 11.88% year-over-year from $23.1 billion in Q2 2025.

Analysis

Viatris (VTRS) Goodwill & Intangibles (2019 - 2026) Analysis & Trends

Viatris has reported Goodwill & Intangibles for 8 years, with the latest figure at $20.3 billion in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 11.88% year-over-year to $20.3 billion in Q2 2026; TTM through Jun 2026 was $20.3 billion, a 11.88% decrease from a year earlier, with the FY2025 full-year figure at $21.9 billion, down 16.59% from the prior year.
  • Goodwill & Intangibles was $20.3 billion for Q2 2026 at Viatris, down from $21.2 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $36.2 billion in Q1 2022, with the low at $20.3 billion in Q2 2026.
  • Average Goodwill & Intangibles over 5 years is $28.1 billion, with a median of $28.3 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles declined 4.56% in 2023, then declined 19.78% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $33.0 billion in 2022, then fell by 12.06% to $29.0 billion in 2023, then fell by 9.79% to $26.2 billion in 2024, then retreated by 16.59% to $21.9 billion in 2025, then declined by 6.98% to $20.3 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $20.3 billion (Q2 2026), $21.2 billion (Q1 2026), and $21.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.33 Bn
Mar 31, 2026 21.17 Bn
Dec 31, 2025 21.86 Bn
Sep 30, 2025 22.45 Bn
Jun 30, 2025 23.07 Bn
Mar 31, 2025 23.12 Bn
Dec 31, 2024 26.20 Bn
Sep 30, 2024 27.54 Bn
Jun 30, 2024 27.74 Bn
Mar 31, 2024 28.83 Bn
Dec 31, 2023 29.05 Bn
Sep 30, 2023 31.56 Bn
Jun 30, 2023 32.62 Bn
Mar 31, 2023 33.27 Bn
Dec 31, 2022 33.03 Bn
Sep 30, 2022 33.07 Bn
Jun 30, 2022 34.62 Bn
Mar 31, 2022 36.23 Bn
Dec 31, 2021 38.25 Bn
Sep 30, 2021 39.16 Bn